deltatrials
Completed NA NCT00005893

Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

Sponsor: Fairview University Medical Center

Conditions Neutropenia Red-Cell Aplasia, Pure Sickle Cell Anemia Thalassemia Major
Interventions Bone marrow transplantation anti-thymocyte globulin busulfan cyclophosphamide
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Jun 30, 2000

A NA clinical study on Neutropenia and Red-Cell Aplasia, Pure, this trial is completed. The trial is conducted by Fairview University Medical Center and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Jun 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fairview University Medical Center
Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Minneapolis, United States